Pulmonary and Critical Care Medicine

Physician Photo

Gregory D. Lewis, MD

Director, Mass General Cardiopulmonary Exercise Laboratory

  • Phone: 617-726-9554
Departments
Cardiology
Department of Medicine

Specialties

  • Critical Care Center
  • Cardiac Intensive Care Unit
  • Heart Center
  • Heart Failure & Cardiac Transplant Program
  • Heart Failure/Transplant
  • Cardiac Resynchronization Therapy Program
  • Cardiovascular Performance Program
  • Transplant Center
  • Heart Transplant
Clinical Interests
Heart failure
Cardiopulomonary exercise testing and hemodynamics
Pulmonary hypertension
Exercise physiology
Cardiac performance in athletes
Diastolic dysfunction
Locations
Boston: Massachusetts General Hospital
Medical Education
MD, University of Rochester School of Medicine and Dentistry
Residency, Massachusetts General Hospital
Fellowship, Massachusetts General Hospital
Board Certifications
Cardiovascular Disease, American Board of Internal Medicine
Gender
Male
Patient Age Group
Adult
Accepting New Patients
Yes

Biography

Since arriving at MGH for my medical residency training in 1999 I have had the privilege of teaching as a chief resident in internal medicine and as a cardiology attending, providing clinical care to patients with a broad range of cardiovascular diseases, and conducting research. As an investigator at MGH I have published over 20 manuscripts in fields ranging from the evaluation of novel therapies for heart failure to mechanisms of exercise intolerance in cardiovascular disease and metabolic response patterns to exercise. I am particularly interested in the role of the lung circulation in mediating exercise intolerance in patients with heart failure. Our team of investigators is also interested in understanding the molecular mechanisms of exercise adaptation through mass spectrometry-based metabolic profiling through several ongoing projects in collaboration with the Broad Institute and Dr. Robert Gerszten. My clinical interests parallel my research interests and focus on improving cardiac performance in patients with a variety of cardiovascular diseases. As a staff member in the recently established Cardiac Performance Program I look forward to offering state of the art cardiopulmonary exercise testing to a broad spectrum of individuals- from patients with heart failure to athletes- in an effort to further understand and improve cardiac performance.

Research

As an investigator I combine my background in biochemistry and metabolomics with physiologic phenotyping of myocardial ischemia and heart failure. I worked with Dr. Marc Semigran to test the hypothesis that selective pulmonary vasodilation with the phosphodiesterase 5 inhibitor, sildenafil, would augment exercise performance in patients with heart failure (HF). We found that both one-time administration of sildenafil and 12-weeks of treatment improved peak VO2 proportionate to pulmonary vasodilation (see Circulation manuscripts, 2007). This work is currently being extended to HF with preserved ejection fraction (HFpEF) in an NIH-Heart Failure Network trial to determine if sildenafil improves peak VO2 in HFpEF. Our group is currently pursuing several other studies using CPx to characterize HF.

In parallel, complimentary work, I have been working at the Broad Institute since 2005 where I helped to establish a >200-component liquid-chromatography mass-spectrometry based platform to measure small molecules in human plasma. This methodology was described in 3 first author publications in 2008-2010, including a manuscript in JCI on metabolic profiling of myocardial injury and a study in Science Translational Medicine describing metabolic changes induced by exercise in more and less fit individuals. My NIH K23 Career Development Award focuses on the application of metabolic profiling to define metabolic signatures of myocardial injury and heart failure. My ultimate goal is to define metabolic signatures of ischemia and heart failure that will guide strategies to redress metabolic derangements.

Publications

Please see Pubmed for a complete list

Lewis GD, Shah R, Shahzad K, et al. Sildenafil Improves Exercise Capacity and Quality of Life in Patients with Systolic Heart Failure and Secondary Pulmonary Hypertension. Circulation. 2007.116:1555-1562.

Lewis GD, Gona P, Benjamin EJ, et al. Exercise Blood Pressure and the Risk of Incident Cardiovascular Disease: The Framingham Heart Study. Am J Cardiol 2008, Jun 1;101(11):1614-20

Lewis GD, Shah RV, Systrom DM, et al. Determinants of Ventilatiory Efficiency in Heart Failure. Circulation Heart Failure, 2008; 1: 227-233

Lewis GD, Farrell L, Wood MJ, et al. Metabolic Signatures of Exercise in Human Plasma. Science Translational Medicine. 2010;2(33)

Advanced blood analysis may speed diagnosis of heart attacks

Study of 'planned' heart attacks identifies markers that could improve treatment, save lives.

Advanced Technologies: When, Who, Why? Patient Selection to Optimize Therapeutic Outcomes

Experts from the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care present their experience and provide a practical guide to clinical decision making for patients with heart failure, pulmonary embolism and cardiogenic stroke.

Detailed metabolic profile gives "chemical snapshot" of the effects of exercise

Using a system that analyzes blood samples with unprecedented detail, a team led by MGH researchers has developed the first "chemical snapshot" of the metabolic effects of exercise.

Cardiac Unit Associates
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-726-9554
Fax: 617-726-4105